Kcat Enzymatic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-11-2024
- Paid Up Capital ₹ 0.12 M
as on 17-11-2024
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.64 M
as on 17-11-2024
- Revenue 88.87%
(FY 2023)
- Profit 96.86%
(FY 2023)
- Ebitda 1094.84%
(FY 2023)
- Net Worth 16919.75%
(FY 2023)
- Total Assets 2412.74%
(FY 2023)
About Kcat Enzymatic
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹6.64 M.
Naganand Doraswamy, Pravin Ramalingam, Roopal Pillai, and One other member serve as directors at the Company.
- CIN/LLPIN
U73100KA2018PTC116908
- Company No.
116908
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Kcat Enzymatic?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Ramalingam  | Director | 26-Sep-2018 | Current |
Naganand Doraswamy  | Nominee Director | 06-Nov-2024 | Current |
| Roopal Pillai | Director | 26-Sep-2018 | Current |
| Immanuel Sigamani | Director | 26-Sep-2018 | Current |
Financial Performance of Kcat Enzymatic.
Kcat Enzymatic Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 88.87% increase. The company also saw a substantial improvement in profitability, with a 96.86% increase in profit. The company's net worth Soared by an impressive increase of 16919.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kcat Enzymatic?
In 2023, Kcat Enzymatic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2024 | ₹6.64 M | Open |
How Many Employees Work at Kcat Enzymatic?
Kcat Enzymatic has a workforce of 38 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kcat Enzymatic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kcat Enzymatic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
